Author response for "Historic real-world outcomes and future benchmarks for patients with diffuse large B-cell lymphoma receiving first- and second-line therapy in Austria – a large single-center experience"
Michael Leisch(Paracelsus Medical University), Thomas Melchardt(Paracelsus Medical University), Dominik Kiem(Paracelsus Medical University), Bernd Schöpf(Innsbruck Medical University), Richard Greil, Mayer Marie-Christina, Gianfranco Pocobelli, Anton Kugler(Paracelsus Medical University), Alexander Egle(Paracelsus Medical University), Christoph Grabmer(Paracelsus Medical University)
Cited by 0
Related Papers
Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas
|International Journal of Mass Spectrometry|2007|276
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
|Blood|2015|186
OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
|Nature Communications|2020|139
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia
|Cancer|2010|65
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2b
|American Journal of Hematology|2014|54